SCHEMBL26014843

SCHEMBL26014843

O=C(O)CCc1ccc(OCCNC(=O)C2CCN(CC(=O)O)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PKM P14618 1/20 0.51
▸ EPHX2 P34913 1/20 0.51
▸ HRH3 Q9Y5N1 3/20 0.48
▸ LTA4H P09960 2/20 0.48
▸ FFAR1 O14842 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ ITGB3 P05106 1/20 0.46
▸ ITGA2B P08514 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ S1PR1 P21453 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25357494 0.85 HRH3 (0.48) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL25357478 0.85 HRH3 (0.48) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL19692527 0.74 DRD2 (0.58) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL19692568 0.73 HRH3 (0.62) KMT2AMEN1HRH3
SCHEMBL7139644 0.71 LTA4H (0.72) LTA4H
SCHEMBL9730574 0.70 NPC1 (0.77) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL19692617 0.70 KMT2A (0.59) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL8541454 0.69 ABCB1 (0.59) KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL29532540 0.69 RAB9A (0.59) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL8474870 0.69 CA12 (0.60) KMT2AFFAR1LMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP KMT2A 3083/4885MEN1 1901/4885NPC1 3981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback